Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

BACKGROUND: Safety data is required to be collected in all clinical trials and can be separated into two types of data, adverse events and serious adverse events. Often, these types of safety data are collected as two discrete data sets, where adverse events that also meet the criteria for seriousne...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Elizabeth C., Dunn, David, Cook, Adrian D., Clamp, Andrew R., Sydes, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495966/
https://www.ncbi.nlm.nih.gov/pubmed/32943106
http://dx.doi.org/10.1186/s13063-020-04718-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495966/
https://www.ncbi.nlm.nih.gov/pubmed/32943106
http://dx.doi.org/10.1186/s13063-020-04718-z

Ejemplares similares